Cargando…

Volumetric modulated arc therapy is superior to conventional intensity modulated radiotherapy - a comparison among prostate cancer patients treated in an Australian centre

BACKGROUND: Radiotherapy technology is expanding rapidly. Volumetric Modulated Arc Therapy (VMAT) technologies such as RapidArc(® )(RA) may be a more efficient way of delivering intensity-modulated radiotherapy-like (IM) treatments. This study is an audit of the RA experience in an Australian depart...

Descripción completa

Detalles Bibliográficos
Autores principales: Fogarty, Gerald B, Ng, Diana, Liu, Guilin, Haydu, Lauren E, Bhandari, Nastik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3179721/
https://www.ncbi.nlm.nih.gov/pubmed/21892944
http://dx.doi.org/10.1186/1748-717X-6-108
_version_ 1782212547287449600
author Fogarty, Gerald B
Ng, Diana
Liu, Guilin
Haydu, Lauren E
Bhandari, Nastik
author_facet Fogarty, Gerald B
Ng, Diana
Liu, Guilin
Haydu, Lauren E
Bhandari, Nastik
author_sort Fogarty, Gerald B
collection PubMed
description BACKGROUND: Radiotherapy technology is expanding rapidly. Volumetric Modulated Arc Therapy (VMAT) technologies such as RapidArc(® )(RA) may be a more efficient way of delivering intensity-modulated radiotherapy-like (IM) treatments. This study is an audit of the RA experience in an Australian department with a planning and economic comparison to IM. METHODS: 30 consecutive prostate cancer patients treated radically with RA were analyzed. Eight RA patients treated definitively were then completely re-planned with 3D conformal radiotherapy (3D); and a conventional sliding window IM technique; and a new RA plan. The acceptable plans and their treatment times were compared and analyzed for any significant difference. Differences in staff costs of treatment were computed and analyzed. RESULTS: Thirty patients had been treated to date with eight being treated definitely to at least 74 Gy, nine post high dose brachytherapy (HDR) to 50.4Gy and 13 post prostatectomy to at least 64Gy. All radiotherapy courses were completed with no breaks. Acute rectal toxicity by the RTOG criteria was acceptable with 22 having no toxicity, seven with grade 1 and one had grade 2. Of the eight re-planned patients, none of the 3D (three-dimensional conformal radiotherapy) plans were acceptable based on local guidelines for dose to organs at risk. There was no statistically significant difference in planning times between IM and RA (p = 0.792). IM had significantly greater MUs per fraction (1813.9 vs 590.2 p < 0.001), total beam time per course (5.2 vs 3.1 hours, p = 0.001) and average treatment staff cost per patient radiotherapy course ($AUD489.91 vs $AUD315.66, p = 0.001). The mean saving in treatment staff cost for RA treatment was $AUD174.25 per patient. CONCLUSIONS: 3D was incapable of covering a modern radiotherapy volume for the radical treatment of prostate cancer. These volumes can be treated via conventional IM and RA. RA was significantly more efficient, safe and cost effective than IM. VMAT technologies are a superior way of delivering IM-like treatments.
format Online
Article
Text
id pubmed-3179721
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-31797212011-09-25 Volumetric modulated arc therapy is superior to conventional intensity modulated radiotherapy - a comparison among prostate cancer patients treated in an Australian centre Fogarty, Gerald B Ng, Diana Liu, Guilin Haydu, Lauren E Bhandari, Nastik Radiat Oncol Research BACKGROUND: Radiotherapy technology is expanding rapidly. Volumetric Modulated Arc Therapy (VMAT) technologies such as RapidArc(® )(RA) may be a more efficient way of delivering intensity-modulated radiotherapy-like (IM) treatments. This study is an audit of the RA experience in an Australian department with a planning and economic comparison to IM. METHODS: 30 consecutive prostate cancer patients treated radically with RA were analyzed. Eight RA patients treated definitively were then completely re-planned with 3D conformal radiotherapy (3D); and a conventional sliding window IM technique; and a new RA plan. The acceptable plans and their treatment times were compared and analyzed for any significant difference. Differences in staff costs of treatment were computed and analyzed. RESULTS: Thirty patients had been treated to date with eight being treated definitely to at least 74 Gy, nine post high dose brachytherapy (HDR) to 50.4Gy and 13 post prostatectomy to at least 64Gy. All radiotherapy courses were completed with no breaks. Acute rectal toxicity by the RTOG criteria was acceptable with 22 having no toxicity, seven with grade 1 and one had grade 2. Of the eight re-planned patients, none of the 3D (three-dimensional conformal radiotherapy) plans were acceptable based on local guidelines for dose to organs at risk. There was no statistically significant difference in planning times between IM and RA (p = 0.792). IM had significantly greater MUs per fraction (1813.9 vs 590.2 p < 0.001), total beam time per course (5.2 vs 3.1 hours, p = 0.001) and average treatment staff cost per patient radiotherapy course ($AUD489.91 vs $AUD315.66, p = 0.001). The mean saving in treatment staff cost for RA treatment was $AUD174.25 per patient. CONCLUSIONS: 3D was incapable of covering a modern radiotherapy volume for the radical treatment of prostate cancer. These volumes can be treated via conventional IM and RA. RA was significantly more efficient, safe and cost effective than IM. VMAT technologies are a superior way of delivering IM-like treatments. BioMed Central 2011-09-05 /pmc/articles/PMC3179721/ /pubmed/21892944 http://dx.doi.org/10.1186/1748-717X-6-108 Text en Copyright ©2011 Fogarty et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Fogarty, Gerald B
Ng, Diana
Liu, Guilin
Haydu, Lauren E
Bhandari, Nastik
Volumetric modulated arc therapy is superior to conventional intensity modulated radiotherapy - a comparison among prostate cancer patients treated in an Australian centre
title Volumetric modulated arc therapy is superior to conventional intensity modulated radiotherapy - a comparison among prostate cancer patients treated in an Australian centre
title_full Volumetric modulated arc therapy is superior to conventional intensity modulated radiotherapy - a comparison among prostate cancer patients treated in an Australian centre
title_fullStr Volumetric modulated arc therapy is superior to conventional intensity modulated radiotherapy - a comparison among prostate cancer patients treated in an Australian centre
title_full_unstemmed Volumetric modulated arc therapy is superior to conventional intensity modulated radiotherapy - a comparison among prostate cancer patients treated in an Australian centre
title_short Volumetric modulated arc therapy is superior to conventional intensity modulated radiotherapy - a comparison among prostate cancer patients treated in an Australian centre
title_sort volumetric modulated arc therapy is superior to conventional intensity modulated radiotherapy - a comparison among prostate cancer patients treated in an australian centre
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3179721/
https://www.ncbi.nlm.nih.gov/pubmed/21892944
http://dx.doi.org/10.1186/1748-717X-6-108
work_keys_str_mv AT fogartygeraldb volumetricmodulatedarctherapyissuperiortoconventionalintensitymodulatedradiotherapyacomparisonamongprostatecancerpatientstreatedinanaustraliancentre
AT ngdiana volumetricmodulatedarctherapyissuperiortoconventionalintensitymodulatedradiotherapyacomparisonamongprostatecancerpatientstreatedinanaustraliancentre
AT liuguilin volumetricmodulatedarctherapyissuperiortoconventionalintensitymodulatedradiotherapyacomparisonamongprostatecancerpatientstreatedinanaustraliancentre
AT haydulaurene volumetricmodulatedarctherapyissuperiortoconventionalintensitymodulatedradiotherapyacomparisonamongprostatecancerpatientstreatedinanaustraliancentre
AT bhandarinastik volumetricmodulatedarctherapyissuperiortoconventionalintensitymodulatedradiotherapyacomparisonamongprostatecancerpatientstreatedinanaustraliancentre